Related by context. All words. (Click for frequent words.) 89 CD# CEA 86 CEA CD# Her2 78 BiTE antibodies targeting 78 antiangiogenesis therapies 76 MKC# MT 76 Pharmos pipeline 76 sarcoma melanoma 76 Solazed TM 75 XL# anticancer compounds 75 lintuzumab SGN 75 CYT# potent vascular disrupting 75 kidney urologic 75 AAG geldanamycin analog 75 including eniluracil ADH 75 candidates Azedra TM 75 oncolytic virus therapies 74 GVAX ® 74 orally administered inhibitor 73 Completes Patient Enrollment 73 HGS ETR1 mapatumumab 73 agonistic human 73 Budesonide foam crofelemer 73 PORxin TM platforms 73 TKB# 73 RAS MAPK pathway 73 TRAIL receptor antibodies 73 Telik logo TELINTRA 73 clinical trials SGN 73 Crofelemer budesonide foam 73 oral picoplatin 73 chemoattractant receptors 73 vaccines oncolytic virus 73 pharmacogenomic translational research 73 novel VDA molecule 73 VEGFR2 inhibitor 73 Zemiva TM 73 oral prodrug 72 XL# XL# XL# XL# 72 testing huN# DM1 72 oral proteasome inhibitor 72 cMET 72 Prodarsan R 72 TRIOLEX ™ 72 Initiates Phase II 72 4SC AG ISIN DE# 72 oral nucleoside analogue 72 Initiates Enrollment 72 telomerase therapeutic 72 TRIOLEX HE# APOPTONE HE# 72 huC# DM4 72 evaluating picoplatin 72 HGS ETR2 71 humanized therapeutic 71 telomerase inhibitor drug 71 tests miRview TM 71 novel antimitotic agent 71 ® bortezomib 71 products MKC# PP 71 SinuNase TM 71 adhesion molecule EpCAM expressing 71 colorectal bladder 71 Trofex TM 71 RAF kinase VEGFR 71 Additional BiTE antibodies 71 gastro intestinal inflammation 71 Reports Preclinical Data 71 tubulin inhibitor 71 XL# XL# 71 ocular formulation 71 sulfonylhydrazine class 71 psoriasis rheumatoid arthritis 71 hypoxia activated prodrug 71 basal cell carcinoma squamous 71 myelofibrosis polycythemia vera 71 investigational monoclonal antibody 71 sapacitabine CYC# 71 biodefense pathogens 71 Combination REOLYSIN R 71 pralatrexate injection folate analogue 71 essential thrombocythemia ET 71 attach auristatin 71 ATC ovarian cancer 70 Phase 2b Clinical Trial 70 antisense inhibitors 70 Initiates Clinical Trial 70 rxRNA 70 HIV AIDS neuropathic pain 70 novel emulsion formulation 70 fusion enhancers 70 commercialize CorMedix drug 70 ALN PCS 70 ThermoDox ® clinical 70 pentadentate logo R 70 CYT# vascular disrupting 70 dimebon latrepirdine 70 prokinetic agent 70 alvespimycin 70 Immunotherapeutic 70 cancer indications bafetinib 70 Exherin TM 70 CCR9 antagonist 70 LymphoStat B belimumab 70 Zemiva TM Trofex TM 70 accumulate preferentially 70 acetylgalactosamine 6 70 Biogen Genentech 70 Pruvel TM 70 Preclinical Efficacy 70 anionic backbone 70 Begins Dosing 70 K ras mutations 70 receptor tyrosine kinase inhibitor 70 Presents Preclinical Data 70 Trastuzumab DM1 70 P#X# antagonist 70 Personalized Immunotherapy 70 Amigal TM 70 developing ACAPODENE 70 Factor Receptor 70 THR beta agonist 70 refractory chronic lymphocytic 70 sodium thiosulfate STS 70 recurrent metastatic ovarian cancer 70 clinical trials dacetuzumab SGN 70 Multiple Sclerosis Rheumatoid Arthritis 70 TLR7 agonist 70 GVAX R 69 CysDisplay R 69 interferon alpha IFN 69 mertansine 69 R sorafenib tablets 69 MSCRAMM ® 69 Aeolus Pharmaceuticals Announces 69 class mGluR5 inhibitor 69 SinuNase ™ 69 lung pancreatic 69 gastrointestinal disorders ATI 69 Vidaza ® 69 non nucleoside inhibitor 69 generation URAT1 inhibitor 69 dependent cellular cytotoxicity 69 Rigel R# 69 Romidepsin 69 CDK cyclin dependent 69 IMiDs ® 69 visit www.genenews.com 69 Exelixis compounds 69 erlotinib Tarceva ® 69 diagnostic molecular imaging 69 Pruvel ™ prulifloxacin 69 DNA methyltransferase inhibitors 69 triggers apoptosis programmed 69 Spectrum Pharmaceuticals Announces 69 Alfacell proprietary ribonuclease 69 Panzem NCD 69 Panzem R NCD 69 Through Glycoscience R 69 targeted radiotherapeutic 69 RON Notch 69 polysaccharide polymer 69 recombinant PSMA vaccine 69 adecatumumab MT# 69 Hsp# Inhibitor 69 isolated hypertriglyceridemia 69 pipeline GlycoPEG GCSF 69 S1P antibody 69 PNP inhibitor 69 palonosetron hydrochloride Injection Dacogen 69 Preclinical studies suggest 69 Staphylococcus aureus Immune Globulin 69 hypereosinophilic syndrome 69 Merck OSI Pharmaceuticals 69 Luveris R Ovidrel R 69 ALN HPN 69 alpha folate receptor 69 targeting Inflammatory Bowel 69 Phase 1b clinical trials 69 Colaris Colaris AP 69 Elotuzumab 69 Pharmos proprietary 69 potently inhibit 69 Pharma Merck Serono 69 2 inhibitor CYT# 69 Therapeutic Competitors Companies 69 BiovaxID TM 69 CYP#A# CYP#D# 69 active AKT inhibitor 69 pancreatic prostate 69 immunotherapeutic approaches 69 CD# expressing 69 CORT # 69 virus HCV protease inhibitor 69 muscarinic receptor agonist 69 LymphoStat B TM 69 JAK2 Inhibitor 69 XP# XP# 69 ENMD # 69 liver colon rectal 69 PDE4 modulators 69 lymphoid malignancies 69 Ribavirin causes 69 galiximab 69 OMP #M# 69 Vaccine Adjuvant 69 GRNVAC1 69 CTAP# Capsules 69 dasatinib Sprycel ® 69 molecular imaging radiopharmaceutical 68 Kit CD# positive 68 commercializing oxidized glutathione 68 Epidermal Growth Factor Receptor 68 R Saizen R 68 Xcytrin R 68 include PLX IBD 68 5 HT2A serotonin 68 Meets Primary Endpoint 68 Receives Orphan Drug Designation 68 Onalta TM 68 www.telik.com 68 include VALSTAR TM 68 peptidic compound 68 HPV cervical dysplasia 68 mGluR5 negative 68 TRANSDUR ® 68 oral ghrelin agonist 68 Inc. www.micromet inc.com 68 M2 subunit 68 Zemiva ™ 68 IAP inhibitor 68 AstraZeneca PLC Arimidex 68 Oral Calcitonin 68 Provectus Pharmaceuticals specializes 68 IMiDs R 68 tests miRview ™ 68 MEK Inhibitor 68 NS5b 68 Fovea Pharmaceuticals subsidiary 68 Panzem R 68 Oracea TM 68 Delta opioid receptor 68 Ovitrelle R Serostim 68 targeted anticancer biopharmaceuticals 68 anti botulism antibody 68 ATRA IV 68 FOLOTYN ® 68 NicVAX TM 68 solid tumors ZYBRESTAT 68 Trial Evaluating 68 world safest multivalent 68 OvaRex R 68 human IgG1 monoclonal 68 evaluating tivozanib 68 TELINTRA R 68 potently inhibited 68 systemic anaplastic large 68 Presents Positive 68 included Raf kinase 68 targets Galectin receptors 68 INxin TM 68 demonstrated antitumor activity 68 based pretargeting methods 68 Veronate R 68 Peginterferon alfa 2b 68 include Altastaph TM 68 Inc. Nasdaq IMGN 68 HuCAL GOLD R 68 RGB # 68 product platforms AZX# 68 chemosensitizer 68 Achieves Primary Endpoint 68 Initiate Clinical Trial 68 drug pipeline TAFA# 68 selective kinase inhibitor 68 TKM PLK1 68 includes TOLAMBA TM 68 candidate XP# 68 Lenocta TM 68 cyclin dependent kinases CDKs 68 Submits Biologics License Application 68 INSPIRE Trial Phase III 68 PEG SN# 68 drugs FUSILEV 68 pan HDAC inhibitor 68 candidate deforolimus 68 NASH Huntington 68 RNA antagonist 68 bladder ovarian 68 novel therapeutic antibodies 68 acyclovir Lauriad R 68 Kinase Inhibitor 68 humanized monoclonal antibodies 68 Archexin 68 Initiates Clinical 68 Tarvacin Anti Cancer 68 inhibit oxidative stress 68 initiated Phase 1b 68 dependent kinase inhibitor 68 Drug Candidate 68 Quinamed R 68 OncoVex 68 R MSCRAMM 68 ionotropic glutamate receptor antagonists 68 Imetelstat 68 TM Aganocide 68 candidate CRLX# 68 2 methoxyestradiol 68 pancreatic colon 68 IgG1 monoclonal antibody 68 Bayer HealthCare Onyx Pharmaceuticals 68 Sangamo BioSciences Announces 68 ARRY # 68 pathophysiological effects 68 AVI BioPharma Announces 68 non porcine pancreatic 68 aldehyde dehydrogenase ALDH2 deficiency 68 next generation URAT1 68 PMX # heptagonist 68 topical antifungal product 68 Smac mimetics 68 inflammatory autoimmune diseases 68 drug conjugates ADCs 68 TOCOSOL Camptothecin 67 anticancer compounds 67 Merck Serono Nycomed 67 transthyretin TTR 67 developing ostarine selective 67 HCV polymerase inhibitors 67 investigational humanized monoclonal antibody 67 Cardium Therapeutics TM 67 ZFP Therapeutics 67 Epratuzumab 67 include ColorectAlert TM 67 Inc. ProMetic www.prometic.com 67 SAR# [002] 67 trastuzumab Herceptin R 67 Rosetta Genomics Nasdaq ROSG 67 IMPDH inhibitor 67 Initiates Phase III 67 tiapamil 67 Combivir Kivexa 67 lead molecular radiotherapeutic 67 ospemifene 67 alpha antagonist 67 Nuvelo Announces 67 Ph + acute lymphoblastic 67 Darinaparsin 67 Vaccine Protects Against 67 Phase 2b Trial 67 through ImmunoGen collaborations 67 Salix Pharmaceuticals Announces 67 hypoxia selective 67 Dyax logo 67 imatinib Gleevec ® 67 metaglidasen 67 mda 7 67 metastatic colorectal 67 ovarian breast 67 pan histone deacetylase 67 development peramivir neuraminidase 67 Phase 2a clinical trials 67 ASONEP ™ 67 PI3K/Akt pathway inhibitor 67 Azedra TM Onalta TM 67 TÎ ² 4 67 Brentuximab Vedotin SGN 67 Successfully Completes Phase 67 Intravenous Human 67 TRACON Pharmaceuticals 67 OMP #R# 67 DepoCyt ® Abelcet ® 67 TRAIL receptor antibody mapatumumab 67 Advancing Drugs 67 Nicotine Conjugate Vaccine 67 Adenoviral 67 alfimeprase direct 67 Refractory Hodgkin Lymphoma 67 Files IND 67 liver cancers hypercholesterolemia 67 PRN FDA Approves 67 Submits Response 67 Commences Phase 67 personalized dendritic cell 67 Factor VIIa 67 Yamanaka recipe 67 include Healive TM 67 lexidronam injection 67 Evoltra ® 67 5 HT2A inverse 67 anti CD3 monoclonal 67 Vascular Disrupting Agent 67 mitogen activated ERK kinase 67 hyaluronidase enzyme 67 CD4 monoclonal antibody 67 FOLFOX6 chemotherapy regimen 67 anti amnesic 67 XOMA 3AB biodefense 67 Phase Ib clinical trials 67 DG# compounds targeting 67 deCODE AF TM 67 ASG 5ME dacetuzumab SGN 67 hypercholesterolemia liver 67 selective modulator 67 TransVax TM 67 vapreotide acetate 67 SIX RO ROG 67 acetonide FA 67 Canvaxin TM 67 familial amyloidotic polyneuropathy FAP 67 novel tubulin binding 67 delta opioid receptor 67 myeloproliferative diseases 67 TTR amyloidosis 67 PEGylated docetaxel 67 vaccine GRNVAC1 67 Pentad TM 67 advanced metastatic renal 67 Array BioPharma Reports 67 Annamycin 67 AKT inhibitor 67 clinical trials Archexin 67 dacetuzumab SGN 67 BioSante Pharmaceuticals Announces 67 candidates Azedra 67 gastrointestinal mucositis 67 selective immunoproteasome inhibitor 67 rheumatoid arthritis juvenile idiopathic 67 Solazed ™ 67 triciribine phosphate monohydrate 67 substantially excreted 67 HCV polymerase 67 Aurexis R 67 Phase #b/#a clinical 67 Zalypsis 67 ImmunoGen TAP technology 67 protein tyrosine phosphatase 1B 67 Pruvel ™ 67 tramiprosate Alzhemed TM 67 clinical trials lintuzumab SGN 67 Company Nasdaq RGDX 67 IMiDs ® compound 67 PSMA ADC 67 sorafenib tablets 67 monoclonal antibody IgG1 Mab 67 hemorrhagic fever viruses 67 monoclonal antibody conjugated 67 LHRH receptor positive 67 Presents Preclinical 67 MAGE A3 ASCI 67 PROSTASCINT R 67 Shigatoxin producing E. coli 67 platform HDL Mimetic 67 carcinoid syndrome diabetes 67 TELINTRA 67 synthetic cannabinoid library 67 R lenalidomide 67 gastrointestinal stromal 67 Disease IBD 66 diabetes irritable bowel 66 rheumatoid arthritis inflammatory bowel 66 Aganocide 66 InNexus Biotechnology Announces 66 biomimetics non 66 Genentech sanofi aventis 66 non nucleoside HCV 66 tranquilizers diazepam 66 diarrhea fatigue asthenia 66 Wafer polifeprosan 66 Thiovir 66 include GALNS N 66 targets EpCAM expressing 66 Tezampanel 66 apoptosis inducer 66 molecular imaging radiopharmaceuticals 66 Asentar TM 66 HuCAL PLATINUM ® CysDisplay 66 trastuzumab DM1 T DM1 66 myeloproliferative neoplasms MPNs 66 retinoic acid receptor 66 NU# direct 66 peptibody 66 Inovio clinical 66 modified glutathione analog 66 XmAb ® 66 novel proprietary KL4 66 PROSTVAC VF 66 targeted immunotherapies 66 myocardial infarction ventricular fibrillation 66 targets HGF FGFR 66 IAP inhibitors 66 candidate AQ4N 66 huN# DM1 66 sunitinib Sutent 66 mediated autoimmune diseases 66 selectively inhibit replication 66 estrogen receptor beta agonist 66 anticancer therapeutics 66 Mg Usa 66 ribonucleotide reductase clinically validated 66 PANVAC VF 66 IL# PE#QQR 66 Anti Tumor 66 radiation chemoradiation 66 receptor inhibiting monoclonal 66 leukemia myeloma 66 cisplatin resistant 66 Civacir TM 66 Inc. AMEX YMI 66 Chronic Lymphocytic Leukemia CLL 66 myelodysplastic myeloproliferative diseases 66 Epothilone D 66 Collaborators Present 66 ALN TTR 66 Licenses Novel 66 infectious diseases autoimmune 66 volociximab 66 ONCONASE R 66 indolent follicular non 66 Demonstrates Positive 66 DPX Survivac 66 bevacizumab Avastin R 66 Demonstrates Significant 66 anti PlGF 66 EGFR HER2 66 Telik Announces 66 Cannabinor 66 antibody MT# 66 Antibody Drug Conjugate 66 XL# inhibits 66 R DepoCyt 66 KRAS mutant 66 targeting miR 66 ASONEP TM 66 platforms GVAX 66 ABL inhibitor completing 66 evaluating satraplatin 66 polyglutamate 66 Other ImmunoGen collaborative 66 Daclizumab 66 including HGF ErbB3 66 oncologic diseases 66 IMA# 66 PEGylated Fab fragment 66 recombinant biopharmaceutical 66 Small interfering RNAs 66 Novel Oral 66 progressive metastatic prostate 66 generation nucleoside analog 66 Copegus R 66 itraconazole Sporanox 66 Aganocide ® 66 unique alkylating agent 66 compound INCB# 66 Phase 2a Trial 66 vinca alkaloids 66 Cloretazine ® 66 Parkinson disease monogenic diseases 66 regarding Aethlon Medical 66 Omacetaxine 66 semi synthetic lipoglycopeptide 66 cutaneous T 66 Solazed 66 prostate secretory 66 MKC# MKC# PP 66 ZFP Therapeutic ® 66 Shows Promise Against 66 LungAlert TM 66 includes VIAtab TM 66 SAR# [004] 66 mGluR5 NAM 66 TO AVOID PREGNANCY WHILE 66 International LAB Pharma 66 androgen receptor modulator 66 dihydrochloride Tablets 66 catheter occlusion 66 Boehringer Ingelheim MedImmune 66 R rilonacept Injection 66 Tumour Vascular Disrupting Agent 66 tumor xenograft models 66 drug conjugates 66 Systemic Delivery 66 MSCRAMM R 66 pharmacological chaperone compounds 66 treat musculoskeletal metabolic 66 R roscovitine 66 cladribine Cladribine Tablets 66 ALS #-# 66 whose tumors overexpress 66 mGluR2 NAM 66 Pivotal Phase III 66 neovasculature 66 systemically administered 66 ® decitabine 66 Entereg R 66 rusalatide acetate 66 SPRYCEL ® 66 Aradigm Logo 66 Present Preclinical Data 66 Marqibo TM 66 Enzastaurin 66 UltiMAb TM 66 tumors GIST 66 induced mucositis 66 colorectal ovarian 66 humanised antibody 66 anti gastrin monoclonal 66 splice variants 66 Exherin 66 serine protease inhibitor CU# 66 Granulocyte Colony Stimulating Factor 66 Trofex ™ 66 selective inverse agonist 66 mocetinostat MGCD# 66 Nasdaq MITI biopharmaceutical 66 OTC BB PVCT 66 Earns Milestone Payment 66 HEPLISAV TM hepatitis B 66 www.micromet inc.com 66 Hedgehog Pathway Inhibitor 66 5 fluorouracil leucovorin 66 selective angiogenic kinase inhibitor 66 RNAi Therapeutic 66 targeted anticancer therapies 66 Epothilones 66 HIV integrase inhibitors 66 proteasome inhibitor 66 angiotensin analog 66 Completes Enrollment 66 Shows Statistically Significant 66 antimitotic 66 Empatic ™ 66 novel orally inhaled 66 commercialize Aganocides 66 Janus kinase 66 Cintredekin Besudotox 66 Announces Poster Presentations 66 Myriad logo BRACAnalysis 66 Selzentry Celsentri 66 castration resistant hormone refractory 66 MTP inhibitor 66 signal detection CTSD 66 PLX MS 66 Syncria albiglutide 66 humanised monoclonal antibody 66 M# rationally 66 HGS ETR1 66 CTAP# Injection 66 cetuximab Erbitux R 66 Azedra TM 66 vivo toxicology 66 Novolimus 66 non constipating irritable 66 Sapacitabine 66 BiTE R 66 XOMA 3AB 66 novel immunotherapies 66 Metastatic Melanoma 66 CG# oncolytic virus 66 Pharmacokinetics PK 66 multiple sclerosis psoriasis 66 orally inhaled migraine 66 TransVax ™ 66 Vidaza R 66 POSIDUR TM ELADUR TM 66 epithelial tumors 66 allosteric modulator NAM 66 highly selective inhibitor 66 plus dacarbazine 66 particularly SANCTURA XR 66 multi kinase inhibitor 65 Friedreich Ataxia FRDA 65 elevated creatine phosphokinase 65 commercializing Loramyc ® 65 AVAX AC Vaccine 65 Humanized Anti 65 company website www.novavax.com 65 Selective Electrochemical Tumor Ablation 65 HER1 65 sanofi aventis Bayer Schering 65 antiangiogenic activity 65 Preclinical Study 65 albiglutide 65 Cytogen marketed 65 Nasdaq XTLB 65 ARIAD Announces 65 Arno Therapeutics 65 Cephalon GlaxoSmithKline 65 Posiphen TM 65 compound perifosine 65 dasatinib Sprycel 65 #/#/# Cytokinetics Incorporated 65 fibrin derived 65 Recombinant Human 65 RhuDex R 65 AQ4N 65 Antitumor Activity 65 carcinoma mCRC 65 forodesine 65 personalized dendritic 65 relapsed leukemia 65 http:/www.optimerpharma.com 65 IMiDs 65 molecular therapeutics immunotherapies 65 please visit www.abraxane.com 65 antibody MAb 65 Albuferon TM 65 MEK inhibitor RDEA# 65 PDGFR B 65 Amgen Bayer Schering 65 non personalized allogeneic 65 OTC BB PVCT http:/www.pvct.com 65 tumor activated prodrug 65 Onyx Pharmaceuticals Announces 65 BRAF mutant 65 infectious diseases autoimmune diseases 65 polymerase inhibitors 65 ALTROPANE R 65 Vitaxin 65 please visit http:/www.sunesis.com 65 Bezielle 65 CORLUX CORT # 65 Trofex 65 PI3K/mTOR 65 PDE# inhibitors 65 SIRT1 activators 65 Kosan dependence 65 Amgen Neulasta R 65 follicular Non Hodgkin 65 using VIAdel TM 65 neuroendocrine cancers 65 RNAi therapeutic targeting 65 multiple sclerosis rheumatoid arthritis 65 PMX # antibiotic 65 Receptors GPCRs 65 phase III isavuconazole 65 chronic eosinophilic leukemia 65 tumor angiogenesis inhibitors 65 Albuferon albinterferon alfa 2b 65 reversible inhibitor 65 stage antibody MT# 65 metabolism viral replication 65 Preclinical Data 65 MT#/MEDI-# 65 CoTherix logo 65 GVAX Immunotherapy 65 docetaxel Taxotere R 65 Fx #A 65 Receive Milestone Payment 65 FUSILEV enhances 65 R roscovitine CDK cyclin 65 candidates bavituximab 65 UCB www.ucb group.com 65 DGAT1 inhibitors 65 blood serum biomarkers 65 AcryMed technologies 65 NS5B polymerase 65 Through Glycoscience 65 Maxy G# 65 cannabinor 65 highly purified pasteurized 65 FUSILEV ® 65 B Anflu R 65 activate SIRT1 65 CRLX# 65 oral transdermal 65 secretory phospholipase A2 65 isoform selective 65 detection reagents 65 MET RET 65 PDX pralatrexate 65 TRANSDUR ™ 65 Antigenics QS 65 lymphomas leukemias 65 relapsed MM 65 Files Investigational 65 trial evaluating PRX# 65 Enterobacter spp 65 antimetastatic activity 65 papillary renal cell carcinoma 65 hematological cancers notably 65 EGFr expressing metastatic colorectal 65 romazarit 65 personalized cellular immunotherapy 65 include ClindaReach TM 65 polyneuropathy HIV DSP 65 GTC recombinant human 65 Aplidin R 65 initiated Phase Ib 65 GRNOPC1 contains 65 CYC# 65 Glufosfamide 65 cortisol synthesis 65 Prodarsan ® 65 selectively inhibited 65 acne impetigo 65 Alzheimer disease cognitive impairment 65 therapeutic monoclonal antibody 65 SCHIZOPHRENIA DISORDERS SUPPORT GROUP 65 aplastic anemia AA 65 NEBIDO VANTAS SUPPRELIN LA 65 Ecallantide 65 novel orally administered 65 Prolongs Survival 65 oral Janus kinase 65 Submits IND 65 antibiotic candidate Ramoplanin 65 AS# amonafide L malate 65 asthma COPD Chronic 65 Vaxfectin R formulated 65 selectively induce apoptosis 65 By JENNIFER LEARN 65 delay bone metastases 65 metastatic pancreatic 65 Safinamide 65 MPH AMEX 65 Sudhir Agrawal D.Phil 65 cosmetic cosmeceutical products 65 taxane derivative 65 proprietary BiTE ® 65 HRPC ovarian cancer 65 Oral Fingolimod 65 TNFerade ™ 65 chemically modified tetracyclines 65 candidate REP# 65 brivanib 65 Initiate Phase III 65 ZFN TM 65 ELADUR TM 65 Atripla combines 65 alpha#beta# integrin 65 Augment TM 65 oral calcitonin licensed 65 HDAC Inhibitor 65 certain protein tyrosine 65 vaccine RiVax TM 65 candidates Augment ™ 65 sunitinib Sutent ® 65 Tyrosine Kinase Inhibitor 65 drug conjugate 65 Fibrosis Foundation Therapeutics 65 radiation sensitizer 65 Aurora Kinase 65 Transgenomic Pharmacogenomics Services 65 markets HP Acthar 65 aurora kinase 65 AMPK activators 65 JAK inhibitors 65 protein kinase inhibitor 65 AVN# Phase 65 Completes Dosing 65 CTA# Injection 65 serious systemic Staphylococcal 65 PrevOnco 65 nilotinib Tasigna ® 65 Nasdaq HALO biopharmaceutical 65 enhance ApoA 65 CAUTIONARY STATEMENT UNDER 65 myeloproliferative disorders 65 cancer immunotherapies 65 psoriasis inflammatory bowel 65 RhuDex TM 65 TransVax tm 65 c Raf kinase 65 PORxin TM 65 preclinical efficacy 65 Naive Patients 65 HCV RNA polymerase 65 ADCC enhanced 65 dyslipidemia hypertension diabetes 65 recurrent NSCLC 65 www.oncogenex.com 65 POTELLIGENT ® Technology 65 topically applied SEPA 65 ALK inhibitors 65 apoptosis proteins 65 rash pruritus nausea 65 novel synthetic PEGylated 65 thrombin component 65 developing Surfactant Replacement 65 Tesmilifene 65 TBC# 65 COPEGUS R 65 muscarinic receptor agonists 65 taxane chemotherapy administered 65 Serostim ® 65 abnormal p# 65 HQK 65 Curaxin CBLC# 65 NS#/#A protease 65 Phase IIb Clinical Trial 65 neuropathic pain metabolic diseases 65 anaphylactic reactions bronchospasm 65 Nasdaq ENMD 65 Azixa MPC 65 GATTEX TM 65 docetaxel Taxotere ® 65 Vicinium TM 65 Anthracycline 65 specific lectin receptors 65 Survivin antagonist 65 pediatric neuroblastoma 65 imetelstat GRN#L 65 rheumatoid arthritis psoriasis 65 phenylalanine ammonia lyase 65 Initiates Phase 65 neuropathic pain spasticity 65 RenaZorb TM 65 DEB# 65 R#/MEM # 65 darinaparsin Zinapar TM 65 hyperphenylalaninemia HPA due 65 DURECT proprietary 65 Namenda Memantine HCl 65 R Bortezomib 65 leukemia multiple myeloma 65 Therapeutic Competitors companiesandmarkets.com adEgemonye 65 Phase 2a Clinical Trial 65 HER2 HER2 65 investigating Serdaxin 65 negative allosteric modulator 65 IMC #B 65 XL# XL# XL# 65 TKM ApoB 65 vascular occlusive diseases 65 novel peptide 65 Phase IIb Trial 65 interferon beta 1a infertility 65 rheumatoid arthritis thrombocytopenia 65 melanoma ovarian 65 gastric pancreatic 65 VEGF inhibitors 65 VentiRx Pharmaceuticals 65 Dementia Related Psychosis 65 CORT # estimates 65 product candidate Lpathomab 65 Orally administered 65 ARIKACE ™ 65 transthyretin TTR mediated amyloidosis 65 Gleevec resistant 65 Locked Nucleic Acid 65 manufactures minimally invasive 65 5 HT6 65 MediGene focuses 65 OTCBB HXBM developer 65 Panzem 65 Aflibercept 64 Ozarelix 64 p# inhibitor 64 ABLYNX 64 used DNA alkylating 64 2A receptor agonist 64 metastatic castration resistant 64 Tß4 64 midstage clinical 64 Investigational Oral 64 Allovectin 7 R 64 metastatic neuroendocrine tumors 64 OTCBB PYTO 64 formerly LymphoStat B 64 Announce License Agreement 64 5 lipoxygenase activating 64 GW# [003] 64 multicenter Phase III 64 histone deacetylase inhibitor 64 MAbs targeting 64 accessories autologous 64 Schering Plough Remicade 64 TNF Tumor Necrosis Factor 64 Squibb Genentech 64 angiogenic responses 64 preclinical compounds 64 Monoclonal Antibody 64 Xanafide 64 Shigamabs ® 64 ELADUR ™ 64 AEG# 64 ovarian lung 64 www.medicago.com 64 potent suppressor 64 HCV protease inhibitors 64 memantine HCl 64 Factor VIIa Factor VIII 64 Ragweed Allergy 64 Locked Nucleic Acid LNA 64 taxane resistant 64 subsidiaries visit http:/www.apricusbio.com 64 leading oral taxane 64 SYN# 64 Submits NDA 64 oral isoform selective HDAC 64 derivatives Radilex TM 64 CB2 selective receptor agonist 64 vinca alkaloid 64 regulate therapeutically important 64 Tramiprosate ALZHEMED TM 64 proliferative diseases 64 www.syntapharma.com 64 Granted Orphan Drug 64 Intravitreal injections 64 androgen receptor AR